Holen Sie sich die Stockscreener-App
2.42
33.70%
0.61
Vorhandelsmarkt:
2.30
-0.12
-4.96%
Schlusskurs vom Vortag:
$1.81
Offen:
$1.71
24-Stunden-Volumen:
1.74M
Relative Volume:
2.94
Marktkapitalisierung:
$304.95M
Einnahmen:
$4.75M
Nettoeinkommen (Verlust:
$-7.83M
KGV:
11.12
EPS:
0.2177
Netto-Cashflow:
$-7.24M
1W Leistung:
+128.30%
1M Leistung:
+124.07%
6M Leistung:
+305.97%
1J Leistung:
+311.15%
1-Tages-Spanne:
$1.6301
$2.485
1-Wochen-Bereich:
$1.01
$2.485
52-Wochen-Spanne:
$0.46
$4.44
Novabay Pharmaceuticals Inc Stock (NBY) Company Profile
Firmenname
Novabay Pharmaceuticals Inc
Sektor
Branche
Telefon
510-899-8800
Adresse
2000 Powell Street, Suite 1150, Emeryville, CA
Vergleichen Sie NBY mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
NBY
Novabay Pharmaceuticals Inc
|
2.42 | 228.08M | 4.75M | -7.83M | -7.24M | 0.2177 |
|
VRTX
Vertex Pharmaceuticals Inc
|
444.64 | 110.88B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
726.21 | 72.79B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
890.11 | 54.76B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
404.46 | 54.85B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
INSM
Insmed Inc
|
189.85 | 41.41B | 447.02M | -1.18B | -906.14M | -6.1812 |
Novabay Pharmaceuticals Inc Stock (NBY) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2019-09-18 | Eingeleitet | Ladenburg Thalmann | Buy |
| 2018-07-06 | Bestätigt | H.C. Wainwright | Buy |
| 2017-11-15 | Bestätigt | Laidlaw | Buy |
| 2017-06-05 | Eingeleitet | ROTH Capital | Buy |
| 2017-03-27 | Eingeleitet | Laidlaw | Buy |
| 2017-02-06 | Eingeleitet | Rodman & Renshaw | Buy |
| 2016-03-07 | Herabstufung | Maxim Group | Buy → Hold |
| 2015-12-14 | Bestätigt | Maxim Group | Buy |
| 2015-04-30 | Fortgesetzt | Maxim Group | Buy |
| 2013-03-06 | Eingeleitet | Ascendiant Capital Markets | Strong Buy |
| 2008-01-03 | Eingeleitet | Dawson James | Speculative Buy |
Alle ansehen
Novabay Pharmaceuticals Inc Aktie (NBY) Neueste Nachrichten
Is Novabay Pharmaceuticals Inc (NBY) positioned for future growth? - Setenews
Is NovaBay Pharmaceuticals Inc a good long term investmentLong-Term Investment Plans & These 3 Stocks Could Change Your Portfolio - earlytimes.in
Is NovaBay Pharmaceuticals Inc. stock undervalued after correctionInsider Selling & Weekly Top Gainers Trade List - Newser
Will NovaBay Pharmaceuticals Inc. (B9P0) stock beat growth indexesQuarterly Market Review & Real-Time Stock Price Movement Reports - Newser
Why Did KALA BIO Shares Jump Over 22% After Hours? - Benzinga
Is NovaBay Pharmaceuticals Inc. stock dividend yield sustainableJuly 2025 Closing Moves & Proven Capital Preservation Tips - Newser
Why NovaBay Pharmaceuticals Inc. stock fits value portfoliosFed Meeting & Fast Gain Stock Trading Tips - Newser
Will NovaBay Pharmaceuticals Inc. stock recover faster than industryPortfolio Gains Summary & Safe Entry Momentum Stock Tips - Newser
Will NovaBay Pharmaceuticals Inc. (B9P0) stock announce a stock split2025 Dividend Review & Safe Capital Investment Plans - Newser
Can NovaBay Pharmaceuticals Inc. stock double in coming years2025 Price Momentum & Growth Oriented Trade Recommendations - Newser
How NovaBay Pharmaceuticals Inc. stock benefits from strong dollar - BỘ NỘI VỤ
Will NovaBay Pharmaceuticals Inc. stock outperform tech sector in 2025Quarterly Growth Report & Breakout Confirmation Alerts - BỘ NỘI VỤ
[S-8] NovaBay Pharmaceuticals, Inc. Employee Benefit Plan Registration | NBY SEC FilingForm S-8 - Stock Titan
What Sparked KALA BIO's Nearly 38% Surge Overnight? - Benzinga
[S-3/A] NovaBay Pharmaceuticals, Inc. Amended Shelf Registration Statement | NBY SEC FilingForm S-3/A - Stock Titan
NovaBay Pharmaceuticals Inc. (NBY) Stock Price | Live Quotes & Charts | AMEX - StocksToTrade
How NovaBay Pharmaceuticals Inc. stock trades under stagflationJuly 2025 Catalysts & Reliable Entry Point Trade Alerts - newser.com
Will NovaBay Pharmaceuticals Inc. (B9P0) stock beat revenue estimatesJuly 2025 Earnings & Weekly Chart Analysis and Guides - newser.com
Will NovaBay Pharmaceuticals Inc. stock deliver compounding returns2025 Stock Rankings & Weekly Setup with ROI Potential - newser.com
Will NovaBay Pharmaceuticals Inc. (B9P0) stock rise with strong economyWeekly Trade Summary & Safe Entry Momentum Tips - newser.com
How NovaBay Pharmaceuticals Inc. (B9P0) stock performs during market turbulence - newser.com
Can NovaBay Pharmaceuticals Inc. stock deliver sustainable ROEMarket Growth Report & High Conviction Investment Ideas - newser.com
Is NovaBay Pharmaceuticals Inc. stock a momentum leaderTrade Volume Report & Daily Oversold Stock Bounce Ideas - newser.com
Is NovaBay Pharmaceuticals Inc. stock suitable for passive index fundsBull Run & Verified Stock Trade Ideas - newser.com
How NovaBay Pharmaceuticals Inc. (B9P0) stock correlates with oil marketsNew Guidance & Verified Momentum Stock Watchlist - newser.com
Is NovaBay Pharmaceuticals Inc. stock at risk of policy regulationWeekly Trade Recap & Intraday High Probability Alerts - newser.com
How NovaBay Pharmaceuticals Inc. stock reacts to stronger dollar - newser.com
Why millennials buy NovaBay Pharmaceuticals Inc. stockMarket Weekly Review & Verified Swing Trading Watchlist - newser.com
Can NovaBay Pharmaceuticals Inc. stock beat analyst consensusEarnings Risk Summary & Real-Time Volume Analysis Alerts - newser.com
Finanzdaten der Novabay Pharmaceuticals Inc-Aktie (NBY)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.45%
0.12%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):